ClinicalTrials.gov
public full text
Public Domain
Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L)
The goal of this clinical research study is to find the highest tolerable doses of surface-controlled water dispersible curcumin (curcumin) that can be given to patients with advanced cancer. The safety of this drug will also be studied.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001)#831984
- Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer#825113
- Placi autoblocante cu gauri combinate cu insertie minim invaziva pentru osteosinteza fracturilor de calcaneu (cu suruburile aferente)#320155
- TAS-102 in Combination With Regorafenib or Fruquintinib for Third-line and Above Advanced Colorectal Cancer#837004
- A Study of RC118 in Patients With Locally Advanced Unresectable/Metastatic Solid Tumours#1149916
Record · ID 1139556
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive